RELAXO FOOTWEARS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 830.6 INR | -0.62% |
|
+0.24% | -8.07% |
| May. 10 | Transcript : Relaxo Footwears Limited, Q4 2024 Earnings Call, May 10, 2024 | |
| May. 10 | Relaxo Footwears' Net Profit Slips in Fiscal Q4 | MT |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company is in a robust financial situation considering its net cash and margin position.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 102.36 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Footwear
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -8.07% | 2.49B | - | ||
| +32.02% | 21.84B | B+ | ||
| +37.48% | 11.41B | C+ | ||
| +10.68% | 10.41B | C | ||
| -0.99% | 8.91B | - | ||
| +55.56% | 8.68B | B- | ||
| +2.65% | 8.19B | A- | ||
| +23.95% | 3.39B | A- | ||
| +81.02% | 3.15B | B- | ||
| -19.56% | 2.03B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
- Stock Market
- Equities
- RELAXO Stock
- RELAXO Stock
- Ratings Relaxo Footwears Limited
